Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete ...

Months after announcing the failure of a mid-stage trial for its personalized neoantigen vaccine in cancer, Gritstone bio ...

Struggling healthcare giant CVS Health is considering breaking up the company, including separating its pharmacy and ...

Obesity startup Metsera is getting a new manufacturing partner and a new CEO. On Tuesday, the well-funded startup announced ...

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

Shat­tuck Labs is lay­ing off 40% of its work­force and dis­con­tin­u­ing its CD47 pro­gram in acute myeloid leukemia and ...

There's major money behind efforts to speed the next significant obesity company to the market. First, it was Metsera, which ...

A New York federal judge dismissed allegations on Monday that Bristol Myers Squibb purposely delayed Breyanzi’s approval to ...

IGM Biosciences will stop working in cancer and shrink its T cell engager pipeline to focus on autoimmune diseases, the ...

A court ruling Friday will open the door to the FDA more tightly regulating stem cell clinics and a commonly-used stem cell ...

California Gov. Gavin Newsom vetoed bipartisan legislation on Saturday that would have reformed pharmacy benefit managers in ...

Johnson & Johnson has called off plans to implement a new rebate model for 340B drug price discounts following threats from ...